Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

VINORELBINE\VINORELBINE: 1,360 Adverse Event Reports & Safety Profile

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now
1,360
Total FAERS Reports
316 (23.2%)
Deaths Reported
326
Hospitalizations
1,360
As Primary/Secondary Suspect
56
Life-Threatening
22
Disabilities

Active Ingredient: VINORELBINE\VINORELBINE TARTRATE ·

First Report: 199605 · Latest Report: 201905

What Are the Most Common VINORELBINE\VINORELBINE Side Effects?

#1 Most Reported
Malignant neoplasm progression
158 reports (11.6%)
#2 Most Reported
Neutropenia
151 reports (11.1%)
#3 Most Reported
Disease progression
105 reports (7.7%)

All VINORELBINE\VINORELBINE Side Effects by Frequency

Side Effect Reports % of Total Deaths Hosp.
Malignant neoplasm progression 158 11.6% 26 25
Neutropenia 151 11.1% 36 22
Disease progression 105 7.7% 26 14
Death 98 7.2% 98 14
Off label use 94 6.9% 11 31
Nausea 89 6.5% 8 23
Anaemia 88 6.5% 17 21
Drug ineffective 81 6.0% 21 7
Diarrhoea 77 5.7% 14 13
Vomiting 71 5.2% 10 18
Thrombocytopenia 69 5.1% 20 14
Febrile neutropenia 67 4.9% 15 31
Fatigue 66 4.9% 6 15
Dyspnoea 64 4.7% 24 18
Pyrexia 61 4.5% 5 43
Neutropenic sepsis 58 4.3% 29 29
Pneumonia 49 3.6% 22 26
Asthenia 45 3.3% 10 9
Constipation 45 3.3% 9 9
Leukopenia 42 3.1% 8 7

Who Reports VINORELBINE\VINORELBINE Side Effects? Age & Gender Data

Gender: 63.2% female, 36.8% male. Average age: 55.1 years. Most reports from: GB. View detailed demographics →

Is VINORELBINE\VINORELBINE Getting Safer? Reports by Year

YearReportsDeathsHosp.
2003 2 0 0
2007 1 1 1
2008 8 1 2
2009 9 2 3
2010 12 3 5
2011 17 2 3
2012 25 4 7
2013 39 7 16
2014 77 22 38
2015 78 19 31
2016 83 16 35
2017 91 15 38
2018 53 17 32
2019 12 0 4

View full timeline →

What Is VINORELBINE\VINORELBINE Used For?

IndicationReports
Breast cancer metastatic 171
Non-small cell lung cancer 163
Breast cancer 106
Hodgkin's disease 99
Product used for unknown indication 95
Her-2 positive breast cancer 86
Lung neoplasm malignant 73
Lung adenocarcinoma 40
Invasive ductal breast carcinoma 33
Diffuse large b-cell lymphoma 28

VINORELBINE\VINORELBINE vs Alternatives: Which Is Safer?

VINORELBINE\VINORELBINE vs VIREAD VINORELBINE\VINORELBINE vs VISIPAQUE VINORELBINE\VINORELBINE vs VISMODEGIB VINORELBINE\VINORELBINE vs VITAMIN A VINORELBINE\VINORELBINE vs VITAMIN B VINORELBINE\VINORELBINE vs VITAMIN D NOS VINORELBINE\VINORELBINE vs VITAMINS VINORELBINE\VINORELBINE vs VOCLOSPORIN VINORELBINE\VINORELBINE vs VOGLIBOSE VINORELBINE\VINORELBINE vs VOLTAREN

Official FDA Label for VINORELBINE\VINORELBINE

Official prescribing information from the FDA-approved drug label.